– USA, PA – AmerisourceBergen Corporation (NYSE: ABC) today announced the election of Werner Baumann and Lauren Tyler to its Board as Independent Directors, effective October 1, 2023, to increase the Board to twelve members, of whom ten are independent.
“We look forward to welcoming Mr. Baumann and Ms. Tyler to AmerisourceBergen’s Board of Directors. Their experience at preeminent multinational companies and unique perspectives will complement our Board’s skill sets and help oversee the company’s long-term, sustainable growth,” said Lead Independent Director, Mark Durcan.
Steve Collis, Chairman and CEO added, “Werner and Lauren’s expertise in their respective fields will be invaluable as we continue executing our long-term strategic vision. Their experience and guidance will be particularly impactful as we become Cencora and continue to advance our role at the center of healthcare.”
About Werner Baumann
Werner Baumann formerly served as Chairman, CEO, and CSO at Bayer AG until his retirement in May 2023. Before becoming CEO in 2016, Mr. Baumann held various leadership roles throughout his 35-year career with the company, including Chief Strategy and Portfolio Officer and CFO. Mr. Baumann earned his B.A. in Economics from the University of Cologne and an M.A. in Economics from RWTH Aachen University.
About Lauren M. Tyler
Lauren Tyler currently serves as EVP and Global Head of Human Resources for J.P. Morgan Asset and Wealth Management, a role she has held since 2015. Before this role, Ms. Tyler served in various leadership roles at JPMorgan Chase & Co., including as Global Chief Auditor and Global Head of Investor Relations. Ms. Tyler is a seasoned financial executive with 35 years of experience in private equity, investment banking, and finance. Ms. Tyler was a director at Alleghany Corporation from January 2019 until its acquisition by Berkshire Hathaway in October 2022. Ms. Tyler earned her B.A. in American Studies from Yale University and an M.B.A. from Harvard Business School.
About AmerisourceBergen
AmerisourceBergen is a leading global pharmaceutical solutions organization centered on improving the lives of people and animals around the world. We partner with pharmaceutical innovators across the value chain to facilitate and optimize market access to therapies. Care providers depend on us for the secure, reliable delivery of pharmaceuticals, healthcare products, and solutions. Our 46,000+ worldwide team members contribute to positive health outcomes through the power of our purpose: We are united in our responsibility to create healthier futures. AmerisourceBergen is ranked #11 on the Fortune 500 and #24 on the Global Fortune 500 with more than $200 billion in annual revenue.
SOURCE: https://www.amerisourcebergen.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
